Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
60,890,488
-
Shares change
-
-5,036,818
-
Total reported value, excl. options
-
$2,810,077,563
-
Value change
-
-$244,072,957
-
Put/Call ratio
-
125%
-
Number of buys
-
56
-
Number of sells
-
-103
-
Price
-
$46.15
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2021
213 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q3 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,890,488 shares
.
Largest 10 shareholders include FMR LLC (6,848,818 shares), BlackRock Inc. (5,757,127 shares), VANGUARD GROUP INC (5,445,821 shares), WELLINGTON MANAGEMENT GROUP LLP (5,182,353 shares), Bellevue Group AG (4,341,992 shares), JPMORGAN CHASE & CO (4,242,985 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,030,741 shares), Rock Springs Capital Management LP (2,556,179 shares), STATE STREET CORP (2,392,890 shares), and Casdin Capital, LLC (2,165,000 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.